Canada markets close in 4 hours 37 minutes

Takeda Pharmaceutical Company Limited (4502.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
4,053.00-46.00 (-1.12%)
At close: 03:15PM JST
Currency in JPY

Valuation Measures4

Market Cap (intraday) 6.43T
Enterprise Value 10.78T
Trailing P/E 36.45
Forward P/E 23.09
PEG Ratio (5 yr expected) 3.24
Price/Sales (ttm)1.55
Price/Book (mrq)0.95
Enterprise Value/Revenue 2.59
Enterprise Value/EBITDA 10.63

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3-10.40%
S&P500 52-Week Change 325.38%
52 Week High 34,873.00
52 Week Low 33,900.00
50-Day Moving Average 34,238.32
200-Day Moving Average 34,311.77

Share Statistics

Avg Vol (3 month) 34.35M
Avg Vol (10 day) 33.59M
Shares Outstanding 51.57B
Implied Shares Outstanding 61.59B
Float 81.55B
% Held by Insiders 10.03%
% Held by Institutions 144.80%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4188
Forward Annual Dividend Yield 44.59%
Trailing Annual Dividend Rate 3184.00
Trailing Annual Dividend Yield 34.49%
5 Year Average Dividend Yield 44.68
Payout Ratio 4163.61%
Dividend Date 3N/A
Ex-Dividend Date 4Mar 28, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 4.28%
Operating Margin (ttm)9.44%

Management Effectiveness

Return on Assets (ttm)2.61%
Return on Equity (ttm)2.76%

Income Statement

Revenue (ttm)4.17T
Revenue Per Share (ttm)2,670.94
Quarterly Revenue Growth (yoy)1.30%
Gross Profit (ttm)N/A
EBITDA 1.21T
Net Income Avi to Common (ttm)178.22B
Diluted EPS (ttm)112.31
Quarterly Earnings Growth (yoy)-11.30%

Balance Sheet

Total Cash (mrq)288.36B
Total Cash Per Share (mrq)183.79
Total Debt (mrq)5.21T
Total Debt/Equity (mrq)77.21%
Current Ratio (mrq)1.06
Book Value Per Share (mrq)4,297.21

Cash Flow Statement

Operating Cash Flow (ttm)731.45B
Levered Free Cash Flow (ttm)-9.88B